Tranexamic acid is an antifibrinolytic agent commonly used to reduce surgical blood loss in major surgeries, including joint replacement surgeries. [1,2] This prospective, double-blind, randomized ...

Rectally administered topical agents have demonstrated efficacy in the maintenance of distal colitis (DC) and proctitis and as they are rarely associated with significant blood drug levels, side ...

Plaque psoriasis is the most prevalent form of the disease. Unsightly skin can cause patients great anguish, raising their frustration with slow or ineffective therapies. This is the approach used by ...

The global Topical Wound Agents Market Size is expected to generate approximately US$ 3,520.0 million by 2033, up from US$ 1,856.6 million in 2023, at a CAGR of 6.6% during the forecast period.

The prevalence of chronic wounds, including venous ulcers and diabetic foot ulcers, is rising due to the implication of demographic and health factors such as the aging population, higher rates of ...

Please provide your email address to receive an email when new articles are posted on . Topical triple-agent fixed-dose combination had the best log-ratio for treatment success. It also proved to be ...

ALTHOUGH various local and topical anesthetics have long been alleged to inhibit bacterial growth it is only recently that this has been critically investigated, at least in relation to bronchoscopy.

The Global Topical Wound Agents Market Size to Grow from USD 1.9 Billion in 2023 to USD 3.7 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 6.89% during ...

At a CAGR of 6.6% over the course of the projected year, the global topical wound agents industry size is anticipated to produce nearly US$ 3,520.0 million by 2033, up from US$ 1,856.6 million in 2023 ...

This medication is an adrenocortical steroid, prescribed for certain skin diseases. This medication is a topical adrenocortical steroid, prescribed for skin disorders such as itching, redness, dryness ...

The FDA approved sofpironium topical gel 12.45% (Sofdra) for primary axillary hyperhidrosis, according to a statement from Botanix Pharmaceuticals. The approval stipulates use in adults and children 9 ...